Impaired ACE2 glycosylation and protease activity lowers COVID-19 susceptibility in Gitelman's and Bartter's syndromes: Low ACE2 glycosilation and Cat-L activity reduce COVID-19.
None This article is protected by copyright. All rights reserved.
['Bertoldi|Giovanni|G|', 'Ravarotto|Verdiana|V|', 'Sgarabotto|Luca|L|', 'Davis|Paul A|PA|', 'Gobbi|Laura|L|', 'Calò|Lorenzo A|LA|https://orcid.org/0000-0002-7534-0128']
ACE2 COVID-19 Bartter's syndrome Cathepsin-L Gitelman's syndrome